This week brought a little of everything — political drama, economic uncertainty, and, if you look past the headlines, some genuinely hopeful news about our health and our future.
Let’s start with what’s happening overseas, because it’s hitting our wallets at home. The United States has been at war with Iran since late February, and this week, something rare happened: members of Congress from both parties stood up and said enough. The House of Representatives voted 215 to 208 to pass a war powers resolution directing President Trump to end the conflict. Four Republican members broke with their party to support the measure alongside Democrats. One of them, Rep. Thomas Massie of Kentucky, put it simply: “People are tired of this. They’re tired of $5 gallon gas and $6 gallon diesel, and fertilizer we can’t afford to put on our fields.” That’s the real story — not just a vote in Washington, but farmers who can’t afford to plant and families stretching every dollar at the pump. The resolution is largely symbolic for now, but it’s a sign that the human cost of this war is registering in places that matter.
On the economy, the picture is mixed. Our country added 172,000 jobs in May — the third month in a row of solid hiring — and unemployment held steady at 4.3%. That’s genuinely good news, and it means more Americans are working. But paychecks aren’t stretching as far as they should, because prices — especially for food and gas — have climbed sharply this year. Tariffs on imported goods have more than quintupled since last year, and that cost has quietly worked its way into grocery bills and hardware stores across the country. We’re a resilient people, but a lot of families are having to make harder choices right now.
Now for the news that really lifted our spirits this week: the medical world delivered two remarkable breakthroughs. Scientists have developed a new drug called daraxonrasib that nearly doubles survival rates for pancreatic cancer — one of the deadliest forms of the disease, killing roughly 50,000 Americans each year. Researchers have long struggled to find effective treatments, and this one targets a genetic mutation found in most cases. The second breakthrough: an AI-designed universal coronavirus vaccine passed its first human safety trial. Unlike our current COVID vaccines, this one is designed to work across multiple coronaviruses, potentially offering longer-lasting protection without the need for annual updates. Both of these advances are still working through the pipeline, but they represent the kind of progress that reminds us why we keep funding research and believing in science.
We also mark something special today — the Bruce Springsteen Center for American Music officially opened at Monmouth University in New Jersey. In a week full of conflict and noise, it felt right to take a moment and celebrate something purely American: the music that has told our stories for generations.
We’re watching a lot of moving pieces right now. But what we see in the science labs, in the bipartisan moments in Congress, and in the communities celebrating Pride this month — is a country still working hard to get things right.